Ontology highlight
ABSTRACT: Introduction
Triple-negative breast cancer (TNBC) remains the most aggressive subtype of breast cancer, and effective therapeutic strategies are needed. Estrogen-related receptor alpha (ERRα) is considered a promising target for managing TNBC.Objectives
Here, we aimed to screen natural products to find downregulator of ERRα and elucidate its mechanism of action.Methods
TNBC cells (MDA-MB-231, MDA-MB-468, MDA-MB-453, and BT-549) were used for in vitro studies, and a subcutaneous MDA-MB-231 tumor model was created for in vivo studies. Immunofluorescence assessed protein distribution, while competitive activity-based protein profiling identified potential target proteins. Co-immunoprecipitation detected protein interactions and modifications, and a luciferase reporter
SUBMITTER: Zhang Z
PROVIDER: S-EPMC12627351 | biostudies-literature | 2025 Nov
REPOSITORIES: biostudies-literature